World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
41193
World Ranking
7917
National Ranking
4121

Lynette M. Sholl publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lynette M. Sholl sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,025 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lynette M. Sholl D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lynette M. Sholl sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lynette M. Sholl is affiliated with Brigham and Women's Hospital in the United States. Their research spans multiple domains within medicine, focusing particularly on pulmonary and respiratory medicine, oncology, and molecular biology. The scientist's published works demonstrate a significant contribution to fields such as cancer research and surgery, integrating molecular biology techniques and clinical approaches.

The primary areas of study for Lynette M. Sholl include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, their subfields consist of:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Cancer Research
  • Molecular Biology
  • Surgery

The scientist's research covers a range of topics emphasizing lung and cancer-related investigations:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal Cancer Treatments and Studies

Lynette M. Sholl has a record of frequent collaboration with several other researchers, including:

  • Mark M. Awad
  • Biagio Ricciuti
  • Jennifer Gordetsky
  • Joao V. Alessi
  • Karen Fritchie

Publications by Lynette M. Sholl appear regularly in specialized journals. The most common publication venues include:

  • Modern Pathology
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Laboratory Investigation
  • Clinical Cancer Research

Recent papers spotlighting diverse aspects of lung cancer and biomarkers include:

  • "PD-L1 as a biomarker of response to immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015," 2021, Journal of Thoracic Oncology
  • "Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer," 2021, Journal of Thoracic Oncology
  • "A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee," 2020, Journal of Thoracic Oncology
  • "IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy," 2020, Journal of Thoracic Oncology

Best Publications

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Dara L. Aisner;Maria E. Arcila

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Deborah Blythe Doroshow;Sheena Bhalla;Mary Beth Beasley;Lynette M. Sholl

  • Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

    Esra A. Akbay;Esra A. Akbay;Shohei Koyama;Julian Carretero;Abigail Altabef;Abigail Altabef

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

  • Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

    Brooke Elizabeth Howitt;Sachet Shukla;Lynette Marie Sholl;Lauren Lee Ritterhouse

  • MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    Mark Magdi Awad;Geoffrey Raymond Oxnard;David M Jackman;Daniel O. Savukoski

  • Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.

    Geoffrey R. Oxnard;Geoffrey R. Oxnard;Yuebi Hu;Kathryn F. Mileham;Hatim Husain

  • Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Christian Rolfo;Philip C. Mack;Giorgio V. Scagliotti;Paul Baas

  • Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    Diana Miao;Diana Miao;Claire A. Margolis;Claire A. Margolis;Natalie I. Vokes;Natalie I. Vokes;David Liu;David Liu

  • PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    Mizuki Nishino;Nikhil H. Ramaiya;Mark M. Awad;Lynette M. Sholl

  • Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The lung cancer mutation consortium experience

    Lynette M. Sholl;Dara L. Aisner;Marileila Varella-Garcia;Lynne D. Berry

  • Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

    Elizabeth P. Garcia;Alissa Minkovsky;Yonghui Jia;Matthew D. Ducar

  • Acquired Resistance to KRASG12C Inhibition in Cancer

    Mark M Awad;Shengwu Liu;Igor I Rybkin;Kathryn C Arbour

  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Christian Rolfo;Philip Mack;Giorgio V. Scagliotti;Charu Aggarwal

  • Institutional implementation of clinical tumor profiling on an unselected cancer population

    Lynette M. Sholl;Khanh Do;Priyanka Shivdasani;Ethan Cerami

  • Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Daniel E. Bauer;Chelsey M. Mitchell;Kelly M. Strait;Christopher S. Lathan

  • Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

    Stephanie Cardarella;Atsuko Ogino;Mizuki Nishino;Mohit Butaney

  • The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

    Ruth Scherz-Shouval;Sandro Santagata;Sandro Santagata;Sandro Santagata;Marc L. Mendillo;Lynette Marie Sholl

  • Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy

    Nishino M;Sholl Lm;Hodi Fs;Hatabu H

Frequent Co-Authors

Pasi A. Jänne
Pasi A. Jänne Harvard University
Mark M. Awad
Mark M. Awad Harvard University
Mizuki Nishino
Mizuki Nishino Harvard University
Neal I. Lindeman
Neal I. Lindeman Brigham and Women's Hospital
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Scott J. Rodig
Scott J. Rodig Harvard University
Jason L. Hornick
Jason L. Hornick Brigham and Women's Hospital
Mari Mino-Kenudson
Mari Mino-Kenudson Harvard University
Yasushi Yatabe
Yasushi Yatabe Nagoya University
Levi A. Garraway
Levi A. Garraway Roche (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a wide range of healthcare careers—and not just for future physicians. Today, diverse online degree programs make it easier than ever to study key medical and health-related fields while maintaining flexibility.

For those interested in leadership roles within healthcare organizations, pursuing online mha programs affordable is an accessible path. These programs teach management skills crucial for running hospitals or clinics. Aspiring advanced practice nurses can consider cheap dnp online programs, which provide advanced clinical expertise and specialized skills.

If your passion is pharmacy, you’ll find several pharmacy school online options that prepare students for pharmacy licensure and practice. For those interested in patient data and information systems, consider earning your credentials through an online mhi program.

Each of these career pathways leverages the flexibility and affordability of online education—helping you advance in the rapidly expanding field of healthcare.

Best Scientists Citing Lynette M. Sholl

Trending Scientists

Recently Published Articles